SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 75 filers reported holding SAVARA INC in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $109,000 | -56.2% | 100,000 | 0.0% | 0.00% | -71.4% |
| Q2 2020 | $249,000 | +17.5% | 100,000 | 0.0% | 0.01% | -22.2% |
| Q1 2020 | $212,000 | -52.7% | 100,000 | 0.0% | 0.01% | -40.0% |
| Q4 2019 | $448,000 | -15.5% | 100,000 | -50.0% | 0.02% | -28.6% |
| Q3 2019 | $530,000 | +11.8% | 200,000 | 0.0% | 0.02% | +90.9% |
| Q2 2019 | $474,000 | -35.7% | 200,000 | +100.0% | 0.01% | -52.2% |
| Q1 2019 | $737,000 | -2.6% | 100,000 | 0.0% | 0.02% | -23.3% |
| Q4 2018 | $757,000 | -32.2% | 100,000 | 0.0% | 0.03% | +25.0% |
| Q3 2018 | $1,116,000 | +58.3% | 100,000 | +110.5% | 0.02% | +84.6% |
| Q4 2017 | $705,000 | – | 47,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |